Related Experiment Video

Updated: May 31, 2026

Screening Ion Channels in Cancer Cells
06:19

Screening Ion Channels in Cancer Cells

Published on: June 16, 2023

Ion channels as targets for cancer therapy

Minghua Li, Zhi-Gang Xiong

    International Journal of Physiology, Pathophysiology and Pharmacology
    |July 16, 2011
    PubMed

    Insights

    This review explores how ion channels, crucial for cell function, are implicated in cancer development. Understanding these channels offers new therapeutic targets for improving cancer treatment outcomes.

    Area of Science:

    • Oncology
    • Molecular Biology
    • Biophysics

    Background:

    • Cancer remains a major global health challenge with limited conventional treatment efficacy.
    • Ion channels, essential membrane proteins, regulate numerous physiological functions.
    • Aberrant ion channel activity is increasingly linked to cancer progression.

    Purpose of the Study:

    • To review the current understanding of ion channel involvement in cancer.
    • To highlight ion channels as potential therapeutic targets for cancer treatment.

    Main Methods:

    • Literature review of recent studies on ion channels and cancer.
    • Analysis of ion channel expression and function in cancer cells.
    • Synthesis of data on specific ion channel families in cancer development.

    Main Results:

    • Abnormal expression/activity of various ion channels (e.g., voltage-gated K+, Na+, Ca2+ channels, TRP channels, ENaC/Deg channels) is associated with cancer.
    • These ion channels influence cancer cell growth, proliferation, migration, and invasion.
    • Specific ion channel dysregulation contributes to tumorigenesis and metastasis.

    Conclusions:

    • Ion channels play critical roles in multiple facets of cancer development.
    • Targeting specific ion channels presents a promising strategy for novel cancer therapies.
    • Further research into ion channel function in cancer is warranted to improve patient outcomes.
    Keywords:
    Ca2+ channelsIon channelsNa+TRP channelscancerepithelial Na+/degenerin family of ion channelstherapeutic targetsvoltage-gated K+

    More Related Videos

    Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

    Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

    Published on: August 25, 2021

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...
    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...
    Targets for Drug Action: Overview01:26

    Targets for Drug Action: Overview

    Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
    Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
    Combination Therapies and Personalized Medicine02:50

    Combination Therapies and Personalized Medicine

    Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
    The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
    Protein Networks02:26

    Protein Networks

    An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
    These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
    Mitogens and the Cell Cycle02:38

    Mitogens and the Cell Cycle

    Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...